New insider Hakim Ben claimed ownership of 3,381,808 shares (SEC Form 3)
3 - PERSHING SQUARE INC. (0002026053) (Issuer)
Live Feed
Delayed 3mPress · Analyst · Insider · Large Ownership Changes
Signed out · 3-min delay · Sign up for real-time
- New insider Israel Ryan claimed ownership of 9,755,884 shares (SEC Form 3)
3 - PERSHING SQUARE INC. (0002026053) (Issuer)
- Buenaventura Announces First Quarter Results
Compañia de Minas Buenaventura S.A.A. ("Buenaventura" or "the Company") (NYSE:BVN, Lima Stock Exchange: BUE.LM)), Peru's largest publicly-traded precious metals mining company, today announced results for the first quarter (1Q26) ended March 31, 2026. All figures have been prepared in accordance with IFRS (International Financial Reporting Standards) on a non-GAAP basis and are stated in U.S. dollars (US$). First Quarter 2026 Highlights: Gold production increased by 8% year-over-year (YoY) primarily driven by the ramp-up of operations at San Gabriel. Consolidated silver production increased by 6% YoY, reflecting higher output at El Brocal, Uchucchacua and Tambomayo. Lead and zinc produ
- EVP, Chief HR Officer Rodriguez Courtney covered exercise/tax liability with 442 shares and converted options into 1,068 shares, increasing direct ownership by 14% to 5,166 units (SEC Form 4)
4 - REPUBLIC SERVICES, INC. (0001060391) (Issuer)
- New insider Ackman William A claimed ownership of 100,000,000 shares (SEC Form 3)
3 - PERSHING SQUARE INC. (0002026053) (Issuer)
- SEC Form 3 filed by new insider Cunningham Ann Michelle
3 - ALTERITY THERAPEUTICS LTD (0001131343) (Issuer)
- Vaccinex Reports 2025 Annual Financial Results
ROCHESTER, N.Y., April 29, 2026 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (OTC:VCNX), a clinical-stage biotechnology company pioneering novel investigational antibody therapies in Alzheimer's, Huntington's disease, and cancer today released financial results for the year ended December 31, 2025. The financial statements have been posted on the company website. About Vaccinex, Inc. Vaccinex, Inc. is a clinical-stage immunotherapy company engaged in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs, including neurodegenerative diseases, cancer, and autoimmune disorders, and is currently initiating a new Phase 2b study in A
- SEC Form 3 filed by new insider Sohn Adam Craig
3 - Z Squared Inc. (0001759186) (Issuer)
- SEC Form 3 filed by new insider Schadel Christopher Ryan
3 - Z Squared Inc. (0001759186) (Issuer)
- New insider Halabu David Elias claimed ownership of 1,412,855 shares (SEC Form 3)
3 - Z Squared Inc. (0001759186) (Issuer)
- SEC Form 3 filed by new insider Fuerst Bryan Eric
3 - Z Squared Inc. (0001759186) (Issuer)
- SEC Form 3 filed by new insider Cooper Kenneth Lyle
3 - Z Squared Inc. (0001759186) (Issuer)
- SEC Form 3 filed by new insider Burke Michelle Ellen
3 - Z Squared Inc. (0001759186) (Issuer)
- SEC Form 4 filed by Former 10% Owner Ares Partners Holdco Llc
4 - X-Energy, Inc. (0002088896) (Issuer)
- PRESIDENT AND CEO Kurtz George sold $2,273,648 worth of shares (5,000 units at $454.73) as part of a pre-agreed trading plan, decreasing direct ownership by 0.23% to 2,208,973 units (SEC Form 4)
4 - CrowdStrike Holdings, Inc. (0001535527) (Issuer)
- NorthWestern Energy Reports First Quarter 2026 Financial Results
First Quarter 2026 Diluted GAAP EPS of $1.03, compared to $1.25 in 2025. First Quarter 2026 Adjusted Diluted Non-GAAP EPS of $1.31, compared to $1.22 in 2025. Affirms 2026 earnings guidance range of $3.68 to $3.83 per diluted share. Affirms record $683 million capital plan for 2026 and 4% to 6% long-term EPS and rate base growth rate. Announces $0.67 per share quarterly dividend - payable June 30, 2026. Received shareholder approval of all merger proposals and reached constructive settlement agreements with certain key intervenors in Montana, Nebraska, and South Dakota. NorthWestern Energy Group, Inc. d/b/a NorthWestern Energy (NASDAQ:NWE) reported financial results for t
- SEC Form 4 filed by Director Raman Prakash
4 - Olema Pharmaceuticals, Inc. (0001750284) (Issuer)
- Amendment: New insider Bartholomew Meghan claimed ownership of 14,511 shares (SEC Form 3)
3/A - RADIAN GROUP INC (0000890926) (Issuer)
- Korea Electric Power Corporation Files 2025 Annual Report on Form 20-F
NAJU, South Korea, April 29, 2026 /PRNewswire/ -- On April 29, 2026, Korea Electric Power Corporation (NYSE:KEP) ("KEPCO") filed its annual report including audited consolidated financial statements on Form 20-F for the year ended December 31, 2025 with the U.S. Securities and Exchange Commission. The report is available at KEPCO's website, kepco.co.kr/eng/index.do (Investor Relations – IR Information – U.S. Filing), as well as the U.S. Securities and Exchange Commission website, www.sec.gov. Investors may request a hard copy of the 2025 Annual Report on Form 20-F, free of charge upon request by sending an email to eunbee.jo@kepco.co.kr. View original content:https://www.prnewswire.com/n